
Healthtrackrx Appoints Keith Koford As Chief Legal Officer
Prior to Healogics, Koford served as Vice President, General Counsel, and Assistant Corporate Secretary for a publicly traded, global medical device and biologics company. There, he led worldwide legal operations across intellectual property, regulatory and clinical affairs, compliance, and reimbursement. His legal career also includes practice at Holland & Knight LLP as part of its International and Cross-Borders Transactions Group and Healthcare and Life Sciences Team.
Before entering the legal profession, Koford began his career in molecular biology, leading a high-throughput DNA sequencing facility at a genomics-based pharmaceutical company, overseeing chemistry, bioinformatics, and electrophoresis divisions. His earlier work in DNA mapping and pharmacogenomics gives him a unique appreciation for the science behind HealthTrackRx's advanced diagnostics.
Koford holds a JD from the University of Florida, an MBA from the Massachusetts Institute of Technology, and a BS in Molecular Biology from Auburn University. He also earned graduate credits toward an MS in Biotechnology at Johns Hopkins University.
"As for my next chapter, it is something about which I am incredibly excited," said Koford. "Anyone who knows me well will immediately see the attraction-particularly those familiar with my background prior to law school. HealthTrackRx is at the forefront of innovation in molecular diagnostics, and I'm thrilled to support its mission from both a legal and scientific perspective."
"Keith's deep experience at the intersection of law, science, and healthcare makes him an exceptional addition to the HealthTrackRx executive team," said Martin Price, CEO. "We're thrilled to welcome him as we continue to expand access to fast, accurate diagnostics and advance responsible antibiotic stewardship."
About HealthTrackRx
HealthTrackRx is the premier infectious disease laboratory delivering next-morning results nationwide. We empower providers with faster answers, actionable insights, and better patient outcomes through advanced molecular diagnostic testing.
SOURCE HealthTrackRx

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Zebu Live 2025 Welcomes Coinbase, Solana, And Other Leaders Together For UK's Biggest Web3 Summit
- Ozak AI Partners With Pyth Network To Deliver Real-Time Market Data Across 100+ Blockchains
- Solotto Launches As Solana's First-Ever Community-Powered On-Chain Lottery
- Stocktwits Launches Stocktoberfest With Graniteshares As Title Partner
- Casper (CSPR) Is Listed On Gate As Part Of Continued U.S. Market Expansion
- VUBE Exchange Announces Unified Account Integration Across VUBE Pro, VUBE Plus, And VUBE Max
Comments
No comment